BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6376538)

  • 1. Detection of Clostridium botulinum type A toxin by enzyme-linked immunosorbent assay with antibodies produced in immunologically tolerant animals.
    Dezfulian M; Bartlett JG
    J Clin Microbiol; 1984 May; 19(5):645-8. PubMed ID: 6376538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of toxigenic Clostridium botulinum type E by enzyme immunoassay.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1991; 14(1):11-5. PubMed ID: 2013205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetics study of immunological response to Clostridium botulinum toxin.
    Dezfulian M; Bitar RA; Bartlett JG
    J Clin Microbiol; 1987 Jul; 25(7):1336-7. PubMed ID: 3301895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum type E toxin.
    Notermans S; Dufrenne J; Kozaki S
    Appl Environ Microbiol; 1979 Jun; 37(6):1173-5. PubMed ID: 384908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Clostridium botulinum type G toxin by enzyme-linked immunosorbent assay.
    Lewis GE; Kulinski SS; Reichard DW; Metzger JF
    Appl Environ Microbiol; 1981 Dec; 42(6):1018-22. PubMed ID: 7316509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-linked immunosorbent assay for detection of Clostridium botulinum toxin type A.
    Notermans S; Dufrenne J; Schothorst M
    Jpn J Med Sci Biol; 1978 Feb; 31(1):81-5. PubMed ID: 351243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of type A, B, E, and F Clostridium botulinum neurotoxins in foods by using an amplified enzyme-linked immunosorbent assay with digoxigenin-labeled antibodies.
    Sharma SK; Ferreira JL; Eblen BS; Whiting RC
    Appl Environ Microbiol; 2006 Feb; 72(2):1231-8. PubMed ID: 16461671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody for the detection of Clostridium botulinum type A toxin.
    Ferreira JL; Hamdy MK; Herd ZL; McCay SG; Zapatka FA
    Mol Cell Probes; 1987 Dec; 1(4):337-45. PubMed ID: 3453424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of Clostridium botulinum type B toxin in the presence of a lethal substance interfering with toxin neutralization.
    Dezfulian M; Bartlett JG
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):105-12. PubMed ID: 3884243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibody to type F Clostridium botulinum toxin.
    Ferreira JL; Hamdy MK; McCay SG; Zapatka FA
    Appl Environ Microbiol; 1990 Mar; 56(3):808-11. PubMed ID: 2180373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relation between toxicity and toxin-related-antigen contents of Clostridium botulinum types C and D cultures as determined by mouse bioassay and ELISA.
    Notermans S; Dufrenne J; Kozaki S
    Jpn J Med Sci Biol; 1982; 35(5-6):203-11. PubMed ID: 6761472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of
    Bano L; Tonon E; Drigo I; Pirazzini M; Guolo A; Farina G; Agnoletti F; Montecucco C
    Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29921757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Induction and modulation of humoral immunity in mice by local nasal administration of botulinum toxoid type B].
    Hörmeyer E; Schultz A; Sailer J; Opitz G; Stünkel K; Petzoldt K
    Berl Munch Tierarztl Wochenschr; 1985 Jan; 98(1):16-9. PubMed ID: 3885940
    [No Abstract]   [Full Text] [Related]  

  • 15. Enzyme linked immunosorbent assay (ELISA) for detection of Clostridium botulinum type B toxin.
    Kozaki S; Dufrenne J; Hagenaars AM; Notermans S
    Jpn J Med Sci Biol; 1979 Aug; 32(4):199-205. PubMed ID: 119079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a monoclonal antibody-based immunoassay for detecting type B Clostridium botulinum toxin produced in pure culture and an inoculated model cured meat system.
    Gibson AM; Modi NK; Roberts TA; Hambleton P; Melling J
    J Appl Bacteriol; 1988 Apr; 64(4):285-91. PubMed ID: 3049499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of the common antigens of Clostridium botulinum, C. sporogenes and C. novyi by an enzyme-linked immunosorbent assay and electroblot transfer.
    Poxton IR
    J Gen Microbiol; 1984 Apr; 130(4):975-81. PubMed ID: 6376703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of Clostridium botulinum type G from Swiss soil specimens by using sequential steps in an identification scheme.
    Sonnabend WF; Sonnabend UP; Krech T
    Appl Environ Microbiol; 1987 Aug; 53(8):1880-4. PubMed ID: 3116935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on the immunological heterogeneity of Clostridium botulinum B type toxin.
    Rymkiewicz D; Sawicki J; Brühl A
    Arch Immunol Ther Exp (Warsz); 1979; 27(5):709-14. PubMed ID: 398207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.